187 related articles for article (PubMed ID: 26775814)
21. Epidemic characteristics of hand, foot, and mouth disease in Shanghai from 2009 to 2010: Enterovirus 71 subgenotype C4 as the primary causative agent and a high incidence of mixed infections with coxsackievirus A16.
Yan XF; Gao S; Xia JF; Ye R; Yu H; Long JE
Scand J Infect Dis; 2012 Apr; 44(4):297-305. PubMed ID: 22176514
[TBL] [Abstract][Full Text] [Related]
22. [Comparisons of epidemiological and clinical characteristics in children with hand-foot-mouth disease caused by Enterovirus 71 and Coxackievirus A16].
Jia L; Zhao CS; Zhang L; Li S; Zhang DT; Liu BW; Wang QY; Li XY
Zhongguo Dang Dai Er Ke Za Zhi; 2011 Aug; 13(8):635-7. PubMed ID: 21849112
[TBL] [Abstract][Full Text] [Related]
23. Quick identification of effective small interfering RNAs that inhibit the replication of coxsackievirus A16.
Wu Z; Gao Y; Sun L; Tien P; Jin Q
Antiviral Res; 2008 Dec; 80(3):295-301. PubMed ID: 18662724
[TBL] [Abstract][Full Text] [Related]
24. A murine model of coxsackievirus A16 infection for anti-viral evaluation.
Liu Q; Shi J; Huang X; Liu F; Cai Y; Lan K; Huang Z
Antiviral Res; 2014 May; 105():26-31. PubMed ID: 24583030
[TBL] [Abstract][Full Text] [Related]
25. A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses.
Cai Y; Ku Z; Liu Q; Leng Q; Huang Z
Vaccine; 2014 May; 32(21):2406-12. PubMed ID: 24657161
[TBL] [Abstract][Full Text] [Related]
26. Characterization of severe hand, foot, and mouth disease in Shenzhen, China, 2009-2013.
Huang Y; Zhou Y; Lu H; Yang H; Feng Q; Dai Y; Chen L; Yu S; Yao X; Zhang H; Jiang M; Wang Y; Han N; Hu G; He Y
J Med Virol; 2015 Sep; 87(9):1471-9. PubMed ID: 25951788
[TBL] [Abstract][Full Text] [Related]
27. Differential interferon pathway gene expression patterns in Rhabdomyosarcoma cells during Enterovirus 71 or Coxsackievirus A16 infection.
Zhang W; Zhang L; Wu Z; Tien P
Biochem Biophys Res Commun; 2014 May; 447(3):550-5. PubMed ID: 24735544
[TBL] [Abstract][Full Text] [Related]
28. Epidemiological and etiological characteristics of hand, foot, and mouth disease in Ningbo, China, 2008-2011.
Ni H; Yi B; Yin J; Fang T; He T; Du Y; Wang J; Zhang H; Xie L; Ding Y; Gu W; Zhang S; Han Y; Dong H; Su T; Xu G; Cao G
J Clin Virol; 2012 Aug; 54(4):342-8. PubMed ID: 22652041
[TBL] [Abstract][Full Text] [Related]
29. Transcriptome sequencing analysis of SH-SY5Y cells infected with EV71 reveals the potential neuropathic mechanisms.
Hu Y; Xu Y; Huang Z; Deng Z; Fan J; Yang R; Ma H; Song J; Zhang Y
Virus Res; 2020 Jun; 282():197945. PubMed ID: 32220619
[TBL] [Abstract][Full Text] [Related]
30. [A pathogen analysis within 174 cases of hand-foot-mouth disease in the summer of 2009].
Fu J; Cui XD; Sun CR; Wang TY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Oct; 25(5):377-80. PubMed ID: 22338230
[TBL] [Abstract][Full Text] [Related]
31. Genomic expression profiling and bioinformatics analysis on diabetic nephrology with ginsenoside Rg3.
Wang J; Cui C; Fu L; Xiao Z; Xie N; Liu Y; Yu L; Wang H; Luo B
Mol Med Rep; 2016 Aug; 14(2):1162-72. PubMed ID: 27279428
[TBL] [Abstract][Full Text] [Related]
32. Hexon-modified recombinant E1-deleted adenoviral vectors as bivalent vaccine carriers for Coxsackievirus A16 and Enterovirus 71.
Zhang C; Yang Y; Chi Y; Yin J; Yan L; Ku Z; Liu Q; Huang Z; Zhou D
Vaccine; 2015 Sep; 33(39):5087-94. PubMed ID: 26296491
[TBL] [Abstract][Full Text] [Related]
33. Transcriptomic analysis identifies candidate genes and functional networks controlling the response of porcine peripheral blood mononuclear cells to mitogenic stimulation.
Wilkinson JM; Dyck MK; Dixon WT; Foxcroft GR; Dhakal S; Harding JC
J Anim Sci; 2012 Oct; 90(10):3337-52. PubMed ID: 23038743
[TBL] [Abstract][Full Text] [Related]
34. Phenotypic and genomic characterization of human coxsackievirus A16 strains with distinct virulence in mice.
Han JF; Yu N; Pan YX; He SJ; Xu LJ; Cao RY; Li YX; Zhu SY; Zhang Y; Qin ED; Che XY; Qin CF
Virus Res; 2014 Jan; 179():212-9. PubMed ID: 24211607
[TBL] [Abstract][Full Text] [Related]
35. Coxsackievirus A16 infection triggers apoptosis in RD cells by inducing ER stress.
Zhu G; Zheng Y; Zhang L; Shi Y; Li W; Liu Z; Peng B; Yin J; Liu W; He X
Biochem Biophys Res Commun; 2013 Nov; 441(4):856-61. PubMed ID: 24211204
[TBL] [Abstract][Full Text] [Related]
36. An outbreak of coxsackievirus A16 infection: comparison with other enteroviruses in a preschool in Taipei.
Wu PC; Huang LM; Kao CL; Fan TY; Cheng AL; Chang LY
J Microbiol Immunol Infect; 2010 Aug; 43(4):271-7. PubMed ID: 20688286
[TBL] [Abstract][Full Text] [Related]
37. A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice.
Ku Z; Liu Q; Ye X; Cai Y; Wang X; Shi J; Li D; Jin X; An W; Huang Z
Vaccine; 2014 Jul; 32(34):4296-303. PubMed ID: 24950363
[TBL] [Abstract][Full Text] [Related]
38. Molecular characterization and complete genome analysis of human enterovirus 71 and coxsackievirus A16 from children with hand, foot and mouth disease in Thailand during 2008-2011.
Puenpa J; Theamboonlers A; Korkong S; Linsuwanon P; Thongmee C; Chatproedprai S; Poovorawan Y
Arch Virol; 2011 Nov; 156(11):2007-13. PubMed ID: 21898187
[TBL] [Abstract][Full Text] [Related]
39. Coxsackievirus A16 infection induces neural cell and non-neural cell apoptosis in vitro.
Li Z; Yu J; Liu L; Wei Z; Ehrlich ES; Liu G; Li J; Liu X; Wang H; Yu XF; Zhang W
PLoS One; 2014; 9(10):e111174. PubMed ID: 25350381
[TBL] [Abstract][Full Text] [Related]
40. Development and characterization of a clinical strain of Coxsackievirus A16 and an eGFP infectious clone.
Deng C; Li X; Liu S; Xu L; Ye H; Qin CF; Zhang B
Virol Sin; 2015 Aug; 30(4):269-76. PubMed ID: 26220729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
